The Gross Margin of Bristol-Myers Squibb Co (BMY) is 75.26%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 75.26% |
| 2023-12-31 | 76.44% |
| 2022-12-31 | 78.18% |
| 2021-12-31 | 79.30% |
| 2020-12-31 | 73.82% |
| 2019-12-31 | 70.15% |
| 2018-12-31 | 71.47% |
| 2017-12-31 | 71.52% |
| 2016-12-31 | 74.65% |
| 2015-12-31 | 76.90% |